Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyager Therapeut (NQ: VYGR )

8.430 -0.200 (-2.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 529,986
Open 8.670
Bid (Size) 8.320 (3)
Ask (Size) 8.600 (7)
Prev. Close 8.630
Today's Range 8.350 - 8.670
52wk Range 6.060 - 14.07
Shares Outstanding 54,393,628
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
VYGR stock results show that Voyager Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Should you consider VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) for growth investing? 
Via Chartmill

Performance

YTD
-6.33%
-6.33%
1 Month
+8.91%
+8.91%
3 Month
+11.66%
+11.66%
6 Month
+23.61%
+23.61%
1 Year
-35.99%
-35.99%

More News

Read More
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
Via InvestorPlace
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
Via Chartmill
Delving into NASDAQ:VYGR's Growth Prospects.
Via Chartmill
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
Via InvestorPlace
Exploring NASDAQ:VYGR's growth characteristics.
Via Chartmill
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Voyager Therapeutics: Q4 Earnings Insights
Via Benzinga
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Via Benzinga
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Preview For Voyager Therapeutics
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Earnings Scheduled For February 28, 2024
Via Benzinga
Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024
Via InvestorPlace
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Voyager Therapeutics stock pops 30% on deal with Novartis
Via MarketBeat
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.